metformin has been researched along with Communicable Diseases in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Communicable Diseases: An illness caused by an infectious agent or its toxins that occurs through the direct or indirect transmission of the infectious agent or its products from an infected individual or via an animal, vector or the inanimate environment to a susceptible animal or human host.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Justice, JN | 1 |
| Gubbi, S | 1 |
| Kulkarni, AS | 1 |
| Bartley, JM | 1 |
| Kuchel, GA | 1 |
| Barzilai, N | 1 |
1 review available for metformin and Communicable Diseases
| Article | Year |
|---|---|
A geroscience perspective on immune resilience and infectious diseases: a potential case for metformin.
Topics: Aged; Communicable Diseases; COVID-19; Humans; Metformin; Multicenter Studies as Topic; RNA, Viral; | 2021 |